Stay updated on GARNET: Anti-PD-1 Antibody Clinical Trial
Sign up to get notified when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.

Latest updates to the GARNET: Anti-PD-1 Antibody Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMajor changes: update revision to v3.2.0 and add new operating-status notice and contact details. Deletion of old revision reference v3.0.2. Minor duplication of a phone number remains but updated.SummaryDifference0.6%
- Check16 days agoChange DetectedCore version update from v3.0.2 to v3.1.0 with added support contact details (phone numbers and email).SummaryDifference0.0%
- Check31 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive changes detected.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.0%
- Check45 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as recent research publications related to cancer treatments, particularly focusing on dostarlimab and its applications in various cancers.SummaryDifference4%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to GARNET: Anti-PD-1 Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.